Related Experiment Video
Updated: Jun 5, 2026
Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Long-term effects of neonatal glutamine-enriched nutrition in very-low-birth-weight infants
Annelies van Zwol1, Josef Neu, Ruurd M van Elburg
1Division of Neonatology, Department of Pediatrics, VU University Medical Center, Amsterdam, The Netherlands.
Insights
Glutamine supplementation in very-low-birth-weight infants shows mixed results for efficacy but no toxicity. Recent research suggests further studies are warranted to explore its benefits in neonatal outcomes.
Area of Science:
- Neonatal Medicine
- Nutritional Science
- Pediatric Research
Background:
- Parenteral or enteral glutamine supplementation has been studied in very-low-birth-weight (VLBW) infants.
- Previous trials found no evidence of toxicity but yielded mixed results on efficacy for specific neonatal outcomes.
- Glutamine supplementation is not standard practice for VLBW infants, with some questioning the need for further research.
Purpose of the Study:
- To review recent research on glutamine supplementation in VLBW infants.
- To evaluate the current evidence regarding the efficacy and necessity of further studies.
- To determine if recent findings warrant continued investigation into glutamine's role in neonatal care.
Main Methods:
- Review of recent scientific literature and clinical trials on glutamine supplementation in VLBW infants.
- Analysis of studies focusing on morbidity, mortality, and overall outcomes.
- Synthesis of data to assess the current state of evidence and future research directions.
Main Results:
- While previous studies showed mixed efficacy, recent research provides new insights into glutamine's potential benefits.
- No toxicity associated with glutamine supplementation has been consistently observed in clinical trials.
- The existing evidence, though debated, suggests that further investigation is justified.
Conclusions:
- Recent research indicates that glutamine supplementation in VLBW infants may warrant additional study.
- Despite mixed historical results, emerging evidence suggests potential benefits that require further exploration.
- Continued research is recommended to clarify the role and optimal use of glutamine in neonatal nutrition for VLBW infants.
Abstract:
Several studies in very-low-birth-weight (VLBW) infants have investigated the effect of parenteral or enteral glutamine supplementation on morbidity, mortality, and outcome in the neonatal period. No evidence of toxicity of glutamine supplementation was found in these clinical trials, but the results for efficacy on a limited number of outcomes have been mixed. The use of glutamine supplementation in VLBW infants has not become routine. Some authors suggest that further study in this area is no longer warranted. In this review, more recent research in the area of glutamine supplementation is described, which suggests additional studies are warranted.
